Orbimed Advisors LLC Dexcom Inc Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $16.5 Million - $21 Million	149,600 Added 106.63%	289,900 $32.9 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $7.66 Million - $9.4 Million	67,100 Added 91.67%	140,300 $19.5 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $5.53 Million - $9.09 Million	73,200 New	73,200 $9.08 Million
Q2 2022 Aug 15, 2022	SELL	$67.99 - $132.89 $10.2 Million - $19.9 Million	-149,900 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $282,240 - $390,599	-3,000 Reduced 1.96%	149,900 $76.7 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $9.75 Million - $12.2 Million	-75,100 Reduced 32.94%	152,900 $82.1 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $7.41 Million - $9.94 Million	-69,400 Reduced 23.34%	228,000 $125 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $1.55 Million - $1.92 Million	18,300 Added 6.56%	297,400 $107 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $4.11 Million - $5.51 Million	52,700 Added 23.28%	279,100 $103 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $7 Million - $11.8 Million	-111,600 Reduced 33.02%	226,400 $91.8 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $4.93 Million - $7.8 Million	103,100 Added 43.89%	338,000 $91 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $5.46 Million - $8.54 Million	-149,100 Reduced 38.83%	234,900 $51.4 Million
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $4.3 Million - $5.3 Million	121,100 Added 46.06%	384,000 $57.3 Million
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $3.46 Million - $4.83 Million	124,200 Added 89.55%	262,900 $39.4 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $3.74 Million - $5.18 Million	138,700 New	138,700 $16.6 Million

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account